Win-Yan joined as a Research Scientist in the Core Antibody Discovery group at UCB after completing her PhD at University College London (2016). During her PhD, Win-Yan developed and characterised a novel vaccine targeting Streptococcus pneumoniae in collaboration with ImmunoBiology, a biotech in Cambridge. This vaccine entered Phase I clinical trials in early 2016. Prior to this, Win-Yan completed her BSc in Biomedical Sciences at University College London (2007), and an MSc in Immunology at Imperial College London (2010). She is also a qualified Science teacher.